Published on
September 9, 2025
- 16:00 GMT
Nexilico Launches Microbial Consortia Discovery Program for Hepatic Encephalopathy
DANVILLE, CA, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Nexilico, a leader in precision microbiome engineering, has initiated a new program to identify and develop novel microbial consortia for the treatment of hepatic encephalopathy (HE). …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...